89,536 Shares in Axcelis Technologies, Inc. $ACLS Acquired by Nuveen LLC

Nuveen LLC acquired a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 89,536 shares of the semiconductor company’s stock, valued at approximately $4,447,000. Nuveen LLC owned 0.28% of Axcelis Technologies as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Axcelis Technologies by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company’s stock worth $220,530,000 after purchasing an additional 43,768 shares during the period. Reinhart Partners LLC. boosted its position in Axcelis Technologies by 39.1% in the 1st quarter. Reinhart Partners LLC. now owns 1,441,022 shares of the semiconductor company’s stock valued at $71,576,000 after buying an additional 404,910 shares during the period. Boston Trust Walden Corp boosted its position in Axcelis Technologies by 0.8% in the 1st quarter. Boston Trust Walden Corp now owns 826,332 shares of the semiconductor company’s stock valued at $41,044,000 after buying an additional 6,216 shares during the period. Dimensional Fund Advisors LP boosted its position in Axcelis Technologies by 11.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 724,585 shares of the semiconductor company’s stock valued at $50,628,000 after buying an additional 71,631 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in Axcelis Technologies by 4.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 386,007 shares of the semiconductor company’s stock valued at $19,173,000 after buying an additional 16,071 shares during the period. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on ACLS. B. Riley raised their price target on shares of Axcelis Technologies from $58.00 to $75.00 and gave the company a “neutral” rating in a research report on Wednesday, June 18th. DA Davidson raised their price target on shares of Axcelis Technologies from $75.00 to $90.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $90.00.

Axcelis Technologies Price Performance

Axcelis Technologies stock opened at $80.91 on Wednesday. The stock has a market cap of $2.54 billion, a P/E ratio of 16.55 and a beta of 1.58. The company has a fifty day simple moving average of $74.30 and a 200-day simple moving average of $62.56. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $113.37. The company has a current ratio of 6.01, a quick ratio of 4.26 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last released its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.40. The business had revenue of $194.54 million during the quarter, compared to analysts’ expectations of $185.15 million. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The company’s revenue for the quarter was down 24.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.55 EPS. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. Equities analysts expect that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.